Morinda citrifolia (Noni) fruit - Phytochemistry, pharmacology, safety

Planta Medica

Volumn 73, Issue 3, 2007, Pages 191-199

  Potterat, Olivier ^a   Hamburger, Matthias ^a  

^a UNIVERSITY OF BASEL   (Switzerland)

Author keywords

Hepatotoxicity; Morinda citrifolia; Noni; Novel food; Pharmacology; Phytochemistry; Rubiaceae

Indexed keywords

2 METHOXY 1,3,6 TRIHYDROXYANTHRAQUINONE; 3,3' BISDEMETHYLPINORESINOL; AMERICANIN A; AMERICANOIC ACID A; AMERICANOL A; ANTHRAQUINONE DERIVATIVE; ASPERULOSIDIC ACID; FATTY ACID AMIDASE; ISOPRINCEPIN; MORINDA CITRIFOLIA EXTRACT; MORINDOLIN; PLANT EXTRACT; UNCLASSIFIED DRUG;

ACUTE HEPATITIS; ANTIINFLAMMATORY ACTIVITY; ANTINEOPLASTIC ACTIVITY; ANTIOXIDANT ACTIVITY; CANDIDIASIS; CHEMICAL COMPOSITION; CLINICAL TRIAL; DOSE RESPONSE; DRUG EFFECT; DRUG INHIBITION; DRUG MONITORING; DRUG SAFETY; DRUG STRUCTURE; EDEMA; HEPATITIS; HUMAN; IN VITRO STUDY; IN VIVO STUDY; LD 50; LIVER TOXICITY; MORINDA CITRIFOLIA; NONHUMAN; PHYTOCHEMISTRY; REVIEW;

FRUIT; HUMANS; MORINDA; PHYTOTHERAPY; PLANT EXTRACTS;

MORINDA CITRIFOLIA; RUBIACEAE;

EID: 34250374867     PISSN: 00320943     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-967115     Document Type: Review

References (73)

1. Wang MY, West BJ, Jensen CJ, Nowicki D, Su C, Palu AK et al. Morinda citrifolia (Noni): a literature review and recent advances in Noni research. Acta Pharmacol Sin 2002; 23: 1127-41.
2. Seidemann J. Noni: Fragwürdige Zauberfrucht aus der Südsee. Pharm Z 2001; 146: 36-40.
3. McClatchey W. From Polynesian healers to health food stores: changing perspectives of Morinda citrifolia (Rubiaceae). Integr Cancer Ther 2002; 1: 110-20.
4. Heinicke RM. The pharmacologically active ingredient of Noni. Pacific Trop Bot Gard Bull 1985; 15: 10-4.
5. Dixon AR, McMillan H, Etkin NL. Ferment this: the transformation of Noni, a traditional Polynesian medicine (Morinda citrifolia, Rubiaceae). Econ Bot 1999; 53: 51-68.
6. Morton JF. The ocean-going Noni, or Indian mulberry (Morinda citrifolia, Rubiaceae) and some of its "colourful" relatives. Econ Bot 1992; 46: 241-56.
7. Nelson SC. Noni cultivation in Hawaii. Fruits and Nuts 2001; 4: 1-4.
8. Nelson SC. Noni cultivation and Production in Hawai'i. In: Proceedings of the 2002 Hawai'i Noni Conference 2003. Nelson SC, editor. University of Hawaii at Manoa: College of Tropical Agriculture and Human Resources; 2003: 33-50.
9. Sang S, Ho CT. Chemical components of Noni (Morinda citrifolia L.) root. ACS SymSer 2006; 925: 185-92.
10. Sang S, Wang M, He K, Liu G, Dong Z, Badmaev V et al. Chemical components in noni fruits and leaves (Morinda citrifolia L). ACS Sym Ser 2002; 803: 134-50.
11. Scientific Committee on Food Opinion of the Scientific Committee on Food on Tahitian Noni® juice. Available at http://europa.eu.int/comm/food/fs/sc/ scf/out151_en.pdf. Expressed December 4 2002 in Brussels.
12. Shovic AC, Whistler WA. Food sources of provitamin A and vitamin C in the American Pacific. Trop Sci 2001; 41: 199-202.
13. Bui AKT, Bacic A, Pettolino F. Polysaccharide composition of the fruit juice of Morinda citrifolia (Noni). Phytochemistry 2006; 67: 1271-5.
14. Wang M, Kikuzaki H, Csisar K, Boyd CD, Maunakea A, Fong SFT et al. Novel trisaccharide fatty acid ester identified from the fruits of Morinda citrifolia (Noni). J Agric Food Chem 1999; 47: 4880-2.
15. Wang M, Kikuzaki H, Jin Y, Nakatani N, Zhu N, Csiszar K et al. Novel glycosides from noni (Morinda citrifolia). J Nat Prod 2000; 63: 1182-3.
16. Samoylenko V, Zhao J, Dunbar DC, Khan IA, Rushing JW, Muhammad I. New constituents from Noni (Morinda citrifolia) fruit juice. J Agric Food Chem 2006; 54: 6398-402.
17. Dalsgaard PW, Potterat O, Dieterle F, Paululat T, Kühn T, Hamburger M. Noniosides E - H, new trisaccharide fatty acid esters from the fruit of Morinda citrifolia (Noni). Planta Med 2006; 72: 1322-7.
18. Levand O, Larson HO. Some chemical constituents of Morinda citrifolia. Planta Med 1979; 36: 186-7.
19. Kamiya K, Tanaka Y, Endang H, Umar M, Satake T. New anthraquinone and iridoid from the fruits of Morinda citrifolia. Chem Pharm Bull 2005; 53: 1597-9.
20. Su BN, Pawlus AD, Jung HA, Keller WJ, McLaughlin JL, Kinghorn AD. Chemical constituents of the fruits of Morinda citrifolia (Noni) and their antioxidant activity. J Nat Prod 2005; 68: 592-5.
21. Kamiya K, Tanaka Y, Endang H, Umar M, Satake T. Chemical constituents of Morinda citrifolia fruits inhibit copper-induced low-density lipoprotein oxidation. J Agric Food Chem 2004; 52: 5843-8.
22. Pawlus AD, Su BN, Keller WJ, Kinghorn AD. An anthraquinone with potent quinone reductase-inducing activity and other constituents of the fruits of Morinda citrifolia (Noni). J Nat Prod 2005; 68: 1720-2.
23. Schripsema J, Caprini GP, Dagnino D. Revision of the structures of citrifolinin A, citrifolinoside, yopaaoside B, and morindacin, iridoids from Morinda citrifolia L. and Morinda coreia Ham. Org Lett 2006; 8: 5337-40.
24. Farine JP, Legal L, Moretau B, Le Quere JL. Volatile components of ripe fruits of Morinda citrifolia and their effects on Drosophila. Phytochemistry 1996; 41: 433-8.
25. Wei GJ, Huang TC, Huang AS, Ho CT. Flavor compounds of Noni fruit (Morinda citrifolia L.) juice. ACS Sym Ser 2004; 871: 52-61.
26. Lachenmeier K, Musshoff F, Madea B, Reusch H, Lachenmeier DW. Authentication of Noni (Morinda citrifolia) juice. Dtsch Lebensmitt Rundsch 2006; 102: 58-61.
27. Liu G, Bode A, Ma WY, Sang W, Ho CT, Dong Z. Two novel glycosides from the fruit of Morinda citrifolia (Noni) inhibit AP-1 transactivation and cell transformation in the mouse epidermal JB6 cell line. Cancer Res 2001; 61: 5749-56.
28. Hirazumi A, Furusawa E. An immunomodulatory polysaccharide-rich substance from the fruit juice of Morinda citrifolia (Noni) with antitumor activity. Phytother Res 1999; 13: 380-7.
29. Furusawa E, Hirazumi A, Story S, Jensen J. Antitumor potential of a polysaccharide-rich substance from the fruit juice of Morinda citrifolia (Noni) on sarcoma 180 ascites tumor in mice. Phytother Res 2003; 17: 1158-64.
30. Wang MY, Anderson GL, Nowicki D. Preventive effect of Morinda citrifolia (Noni) at the initiation stage of mammary breast carcinogenesis induced by 7,12-dimethylbenzo(a)anthracene (DMBA) in female Sprague-Dawley (SD) rats. Cancer Epidemiol Biomark Prev 2002; 11: 1218S.
31. Wang MY, Su C. Cancer preventive effect of Morinda citrifolia (Noni). Ann NY Acad Sci 2001; 952: 161-8.
32. Wang MY, Anderson GL, Nowicki D. Synergistic effect of Tahitian noni juice (TNJ) and methylsulfonylmethane (MSM) on mammary breast cancer prevention at the induction stage of chemical carcinogenesis induced by DMBA in female Sprague-Dawley (SD) rats. Cancer Epidemiol Biomark Prev 2003; 12: 1354S.
33. Nowicki J, Haun J, Peng L, Anderson G, Nowicki D, Wang MY. Antimutagenic activity of Morinda citrifolia (Noni) fruit juice in ICR mice. Cancer Epidemiol Biomark Prev 2005; 14: 1689S.
34. Hornick CA, Myers A, Sadkowska-Krowicka H, Anthony CT, Woltering EA. Inhibition of angiogenic initiation and disruption of newly established human vascular networks by juice from Morinda citrifolia (Noni). Angiogenesis 2003; 6: 143-9.
35. Arpornsuwan T, Punjanon T. Tumor cell-selective antiproliferative effect of the extract from Morinda citrifolia fruits. Phytother Res 2006; 20: 515-7.
36. McKoy MLG, Thomas EA, Simon OR. Preliminary investigation of the anti-inflammatory properties of an aqueous extract from Morinda citrifolia (Noni). Proc West Pharmacol Soc 2002; 45: 76-8.
37. Xu J, McSloy AC, Anderson BK, Goodbee RG, Peek SF, Darien BJ. Tahitian Noni® Equine Essentials TM: a novel anti-inflammatory and COX-2 inhibitor which regulates LPS induced inflammatory mediator expression in equine neonatal monocytes. J Vet Intern Med 2006; 20: 756.
38. Kim SW, Jo BK, Jeong JH, Choi SU, Hwang YI. Induction of extracellular matrix synthesis in normal human fibroblasts by anthraquinone isolated from Morinda citrifolia (Noni) fruit. J Med Food 2005; 8: 552-5.
39. Wang MY, Henley E, Nolting J, Cheerva A, Jensen J, Anderson G et al. The effects of Morinda citrifolia (Noni) fruit juice on serum cholesterol and triglyceride in current smokers. Circulation 2006; 113: E327.
40. Ayanbule F, Wang MY, Peng L, Nowicki J, Anderson G, Nowicki D. Antithrombotic effect of Morinda citrifolia (Noni) fruit juice on the jugular vein thrombosis induced by ferric chloride in male adult SD rats. Arterioscler Thromb Vasc Biol 2006; 26: E104.
41. Zin ZM, Abdul-Hamid A, Osman A. Antioxidative activity of extracts from Menkudu (Morinda citrifolia L.) root, fruit and leaf. Food Chem 2002; 78: 227-31.
42. Su CX, Jensen JC, Zhou BN. Morinda citrifolia (Noni): its effect on insulin secretion by G-protein-coupled receptor systems. San Diego, CA: 229th ACS National Meeting; 2005.
43. Wang MY, Anderson GL, Nowicki D, Jensen J. Protective effect of Morinda citrifolia (Noni) fruit juice against chronic liver injury induced by carbon tetrachloride in female SD rats. Cancer Epidemiol Biomark Prev 2004; 13: 1838S.
44. Wong DKW. Are immune responses pivotal to cancer patient's long term survival? Two clinical case-study reports on the effects of Morinda citrifolia (Noni). Hawaii Med J 2004; 63: 182-4.
45. The Noni study Available at http://www.crch.org/CenStudyNoni.htm. Accessed in 2006.
46. Clinical trial: study of Noni in cancer patients. Available at http://www.clinicaltrials.gov/show/NCT00033878. Accessed in 2006.
47. Issell BF, Gotay C, Pagano I, Franke A. Quality of life measures in a phase I trial of noni. J Clin Oncol 2005; 23: 782S.
48. Ghai G, Ho CT, Rosen RT, Wang M, Boyd CD, Csiszar K. Glycosides from Noni extract for treatment of tumours. US Patent Application 2002 - 150213; 2003.
49. Jensen CJ, Palu AK, Story SP, Jensen S, Su C. Preventative and treatment effects of Morinda citrifolia as a colon cancer cell growth inhibitor. US Patent Application 2002 - 285 334; 2003.
50. Jensen CJ, Palu AK, Lemus D, Fuenzalida M, Mihovilovic D. Anti-angiogenesis effects of Morinda citrifolia. US Patent Application 2002 - 286112; 2004.
51. Palu AK, West BJ, Jensen CJ, Su C, Zhou BN, Story SP. Preventative and treatment effects of Morinda citrifolia as an aromatase inhibitor. US Patent Application 2004 - 192 761; 2004.
52. Su C, West B, Palu A, Hirasumi-Kim A, Jensen CJ, Story S. Morinda citrifolia-based formulation for inhibiting metastasis of carcinogenic cells. PCT International Application WO 2004 098 514; 2004.
53. Wang MY, Jensen CJ, Su C. Preventative effects of Morinda citrifolia on mammary breast cancer. US Patent Application 2005 - 037 101; 2005.
54. West BJ, Jensen CJ, Palu AK, Ogden RV, Gerson S. Method and formulation for treating candidiasis using Morinda citrifolia. US Patent Application 2002 - 294 089; 2003.
55. Gerson S, Palu AK, Zhou BN, Su C, Jensen CJ, Story SP et al. Antifungal effects of Morinda citrifolia. US Patent Application 2003 - 439 596; 2003.
56. Su CX, Jensen CJ, Story SP. Morinda citrifolia juice dietary supplement for reducing cellular damage in the human body. PCT International Application WO 2001-US47203; 2002.
57. European Commission, Commission Decision of 5 June 2003 authorising the placing on the market of "noni juice" (juice of the fruit of Morinda citrifolia L.) as a novel food ingredient under Regulation (EC) Nr. 258/97 of the European Parliament and of the Council. Official Journal of the European Union 2003; L 144/12: 12.6.2003.
58. European Commission Health & Consumer Protection Directorate-General. Opinion of the Scientific Committee on Food on Tahitian Noni® juice. Available at http://europa.eu.int/comm/food/fs/sc/scf/index_en.html. Accessed on December 11, 2002.
59. West BJ, Jensen CJ, Westendorf J, White LD. A safety review of Noni fruit juice. J Food Sci 2006; 71: R100-6.
60. Mancebo A, Scull I, Gonzalez Y, Artega ME, Gonzales BO, Fuentes D et al. Ensayo de toxicidad a dosis repetidas (28 dias) por via oral del extracto acuoso de Morinda citrifolia en ratas Sprague Dawley. Rev Toxicol 2002; 19: 73-8.
61. Chearskul S, Kooptiwut S, Chatchawalvanit S, Onreabroi S, Churintrapun M, Saealamp P et al. Morinda citrifolia has very weak estrogenic activity in vivo. Thai J Physiol Sci 2004; 17: 22-9.
62. Nakanishi K, Sasaki SI, Kiang AK, Goh J, Kakisawa H, Ohashi M et al. Phytochemical survey of Malaysian plants. Preliminary chemical and pharmacological screening. Chem Pharm Bull 1965; 13: 882-90.
63. Wang MY, West BJ, Jensen CJ, Nowicki D, Su C, Palu AK et al. Morinda citrifolia (Noni): a literature review and recent advances in Noni research. Acta Pharmacol Sin 2002; 23: 1127-41.
64. West BJ, Jensen CJ, Westendorf J. Noni juice is not hepatotoxic. World J Gastroenterol 2006; 12: 3616-9.
65. Millonig G, Stadlmann S, Vogel W. Herbal hepatotoxicity: acute hepatitis caused by a noni preparation (Morinda citrifolia). Eur J Gastroenterol Hepatol 2005; 17: 445-7.
66. Stadlbauer V, Fickert P, Lackner C, Schmerlaib J, Krisper P, Trauner M et al. Hepatotoxicity of noni juice: report of two cases. World J Gastroenterol 2005; 11: 4758-60.
67. Bundesinstitut für Riskobewertung. Information Nr. 019/2006 des BfR of March 6. 2006.
68. Yüce B, Gülberg V, Diebold J, Gerbes AL. Hepatitis induced by Noni juice from Morinda citrifolia: a rare case of hepatotoxicity or the tip of the iceberg? Digestion 2006; 73: 167-70.
69. West BJ. Hepatotoxicity from interferon-beta not from Noni juice. Digestion 2006; 74: 47-8.
70. Jensen J, Westendorf J, Wang MY, Wadsworth DP. Noni protects the liver. Eur J Gastroenterol Hepatol 2006; 18: 575-7.
71. Burrowes JD, Van Houten G. Use of alternative medicine by patients with stage 5 chronic kidney disease. Adv Chronic Kidney Dis 2005; 12: 312-25.
72. th Plenary Meeting of the Scientific Panel on Dietetic Products, Nutrition and Allergies, 15-16 February 2006. Available at http://www.efsa.eu.int/science/nda_opinions/ catindex_en.html. Accessed in 2006.
73. Opinion on a request from the Commission related to the safety of Noni juice (juice of the fruits of Morinda citrifolia). EFSA J; 2006; 376: 1-12.